Skip to main content
Top
Published in: Acta Neurochirurgica 4/2018

Open Access 01-04-2018 | Original Article - Pediatrics

Pre-operative neutrophil count and neutrophil-lymphocyte count ratio (NLCR) in predicting the histological grade of paediatric brain tumours: a preliminary study

Authors: J. R. F. Wilson, F. Saeed, A. K. Tyagi, J. R. Goodden, G. Sivakumar, D. Crimmins, M. Elliott, S. Picton, P. D. Chumas

Published in: Acta Neurochirurgica | Issue 4/2018

Login to get access

Abstract

Introduction

The neutrophil-lymphocyte count ratio (NLCR) is an established prognostic marker for renal, lung and colorectal carcinomas and has been suggested to be predictive of histological grade and outcome in adult intracranial tumours. The purpose of this study was to determine whether a correlation of the pre-operative neutrophil count (NC) and NLCR with the final histological grade exists in paediatric intracranial tumours.

Methods

A retrospective analysis was undertaken at a single centre. Patients less than 18 years old at the time of surgery who underwent tumour-related procedures from 2006 to 2015 were included. Patients with recurrent tumours, previous bone marrow transplant and metastases were excluded. Pre-operative full blood counts (FBC), collected before the diagnosis of intracranial pathology and before administration of steroids, were matched with histological diagnosis for each patient. Post-operative FBC was also recorded, together with survival data where applicable.

Results

A total of 116 patients (74 male, 42 female; mean age, 8 ± 0.9 years) with a diagnosis of primary intracranial tumours had pre-operative FBC that could be matched to final histological grade. Pre-operative NC and NLCR were higher with increasing grade of tumour: grade 1 (NC 4.29 109/l, NLCR 2.26), grade 2 (NC 4.59 109/l, NLCR 2.38), grade 3 (NC 5.67 109/l, NLCR 2.72) and grade 4 (NC 6.59 109/l, NLCR 3.31). Patients with WHO grade 1 and 2 tumours pooled together had a lower NC (4.37 95% CI ± 0.67 109/l) compared to WHO grade 3 and 4 patients (6.41 95% CI ± 0.99 109/l, p = 0.0013). The NLCR was lower in grade 1 and 2 tumours (2.29 ± 0.59) (compared to grade 3 and 4 tumours; 3.20 ± 0.76) but this did not reach significance (p = 0.069). The subgroup of patients with pilocytic astrocytoma had a significantly lower NC when compared to patients with high-grade tumours (p = 0.005). Medulloblastoma and supratentorial PNET subgroups had significantly higher NC compared to the low-grade group (p = 0.033, p = 0.002). Post-operative NC was significantly higher in the high-grade tumours (p = 0.034), but no difference was observed for NLCR (p = 0.28).

Conclusions

No evidence exists to support the correlation of pre-operative NC or NLCR to histological diagnosis in paediatric intracranial tumours. Our results indicate that a higher pre-operative NC/NLCR correlates with a higher histological grade of tumour. This suggests that immunological mechanisms may be involved in the pathogenesis of paediatric brain tumours, and a further prospective study is required to substantiate and expand these findings.
Literature
1.
2.
go back to reference Bambury RM, Teo MY, Power DG, Yusuf A, Murray S, Battley JE, Drake C, O'Dea P, Bermingham N, Keohane C, Grossman SA, Moylan EJ, O'Reilly S (2013) The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. J Neuro-Oncol 114:149–154CrossRef Bambury RM, Teo MY, Power DG, Yusuf A, Murray S, Battley JE, Drake C, O'Dea P, Bermingham N, Keohane C, Grossman SA, Moylan EJ, O'Reilly S (2013) The association of pre-treatment neutrophil to lymphocyte ratio with overall survival in patients with glioblastoma multiforme. J Neuro-Oncol 114:149–154CrossRef
3.
go back to reference de Jager CP, Wever PC, Gemen EF, Kusters R, van Gageldonk-Lafeber AB, van der Poll T, Laheij RJ (2012) The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia. PLoS One 7:e46561CrossRefPubMedPubMedCentral de Jager CP, Wever PC, Gemen EF, Kusters R, van Gageldonk-Lafeber AB, van der Poll T, Laheij RJ (2012) The neutrophil-lymphocyte count ratio in patients with community-acquired pneumonia. PLoS One 7:e46561CrossRefPubMedPubMedCentral
4.
go back to reference Gregory AD, Houghton AM (2011) Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 71:2411–2416CrossRefPubMed Gregory AD, Houghton AM (2011) Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 71:2411–2416CrossRefPubMed
5.
go back to reference Han S, Liu Y, Li Q, Li Z, Hou H, Wu A (2015) Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma. BMC Cancer 15:617CrossRefPubMedPubMedCentral Han S, Liu Y, Li Q, Li Z, Hou H, Wu A (2015) Pre-treatment neutrophil-to-lymphocyte ratio is associated with neutrophil and T-cell infiltration and predicts clinical outcome in patients with glioblastoma. BMC Cancer 15:617CrossRefPubMedPubMedCentral
6.
go back to reference Houghton AM (2010) The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances. Cell Cycle 9:1732–1737CrossRefPubMed Houghton AM (2010) The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances. Cell Cycle 9:1732–1737CrossRefPubMed
7.
go back to reference Kumar R, Geuna E, Michalarea V, Guardascione M, Naumann U, Lorente D, Kaye SB, de Bono JS (2015) The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials. Br J Cancer 112:1157–1165CrossRefPubMedPubMedCentral Kumar R, Geuna E, Michalarea V, Guardascione M, Naumann U, Lorente D, Kaye SB, de Bono JS (2015) The neutrophil-lymphocyte ratio and its utilisation for the management of cancer patients in early clinical trials. Br J Cancer 112:1157–1165CrossRefPubMedPubMedCentral
8.
go back to reference Liang C, Li YY (2014) Use of regulators and inhibitors of Pim-1, a serine/threonine kinase, for tumour therapy (review). Mol Med Rep 9:2051–2060CrossRefPubMed Liang C, Li YY (2014) Use of regulators and inhibitors of Pim-1, a serine/threonine kinase, for tumour therapy (review). Mol Med Rep 9:2051–2060CrossRefPubMed
10.
go back to reference Lucas SM, Rothwell NJ, Gibson RM (2006) The role of inflammation in CNS injury and disease. Br J Pharmacol 147(Suppl 1):S232–S240PubMedPubMedCentral Lucas SM, Rothwell NJ, Gibson RM (2006) The role of inflammation in CNS injury and disease. Br J Pharmacol 147(Suppl 1):S232–S240PubMedPubMedCentral
11.
go back to reference Malietzis G, Giacometti M, Kennedy RH, Athanasiou T, Aziz O, Jenkins JT (2014) The emerging role of neutrophil to lymphocyte ratio in determining colorectal cancer treatment outcomes: a systematic review and meta-analysis. Ann Surg Oncol 21:3938–3946CrossRefPubMed Malietzis G, Giacometti M, Kennedy RH, Athanasiou T, Aziz O, Jenkins JT (2014) The emerging role of neutrophil to lymphocyte ratio in determining colorectal cancer treatment outcomes: a systematic review and meta-analysis. Ann Surg Oncol 21:3938–3946CrossRefPubMed
12.
go back to reference Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444CrossRefPubMed Mantovani A, Allavena P, Sica A, Balkwill F (2008) Cancer-related inflammation. Nature 454:436–444CrossRefPubMed
13.
go back to reference Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13:265–270CrossRefPubMed Mantovani A, Bottazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor-associated macrophages. Immunol Today 13:265–270CrossRefPubMed
14.
go back to reference McNamara MG, Lwin Z, Jiang H, Templeton AJ, Zadeh G, Bernstein M, Chung C, Millar BA, Laperriere N, Mason WP (2014) Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression. J Neuro-Oncol 117:147–152CrossRef McNamara MG, Lwin Z, Jiang H, Templeton AJ, Zadeh G, Bernstein M, Chung C, Millar BA, Laperriere N, Mason WP (2014) Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression. J Neuro-Oncol 117:147–152CrossRef
15.
go back to reference Schmidt H, Bastholt L, Geertsen P, Christensen IJ, Larsen S, Gehl J, von der Maase H (2005) Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer 93:273–278CrossRefPubMedPubMedCentral Schmidt H, Bastholt L, Geertsen P, Christensen IJ, Larsen S, Gehl J, von der Maase H (2005) Elevated neutrophil and monocyte counts in peripheral blood are associated with poor survival in patients with metastatic melanoma: a prognostic model. Br J Cancer 93:273–278CrossRefPubMedPubMedCentral
16.
go back to reference Scotton C, Milliken D, Wilson J, Raju S, Balkwill F (2001) Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours. Br J Cancer 85:891–897CrossRefPubMedPubMedCentral Scotton C, Milliken D, Wilson J, Raju S, Balkwill F (2001) Analysis of CC chemokine and chemokine receptor expression in solid ovarian tumours. Br J Cancer 85:891–897CrossRefPubMedPubMedCentral
17.
go back to reference Subeikshanan V, Dutt A, Basu D, Tejus MN, Maurya VP, Madhugiri VS (2016) A prospective comparative clinical study of peripheral blood counts and indices in patients with primary brain tumors. J Postgrad Med 62:86–90CrossRefPubMedPubMedCentral Subeikshanan V, Dutt A, Basu D, Tejus MN, Maurya VP, Madhugiri VS (2016) A prospective comparative clinical study of peripheral blood counts and indices in patients with primary brain tumors. J Postgrad Med 62:86–90CrossRefPubMedPubMedCentral
18.
go back to reference Tumturk A, Ozdemir MA, Per H, Unal E, Kucuk A, Ulutabanca H, Karakukcu M, Canoz O, Gumus H, Coskun A, Kurtsoy A (2017) Pediatric central nervous system tumors in the first 3 years of life: pre-operative mean platelet volume, neutrophil/lymphocyte count ratio, and white blood cell count correlate with the presence of a central nervous system tumor. Childs Nerv Syst 33:233–238CrossRefPubMed Tumturk A, Ozdemir MA, Per H, Unal E, Kucuk A, Ulutabanca H, Karakukcu M, Canoz O, Gumus H, Coskun A, Kurtsoy A (2017) Pediatric central nervous system tumors in the first 3 years of life: pre-operative mean platelet volume, neutrophil/lymphocyte count ratio, and white blood cell count correlate with the presence of a central nervous system tumor. Childs Nerv Syst 33:233–238CrossRefPubMed
19.
go back to reference Zadora P, Dabrowski W, Czarko K, Smolen A, Kotlinska-Hasiec E, Wiorkowski K, Sikora A, Jarosz B, Kura K, Rola R, Trojanowski T (2015) Preoperative neutrophil-lymphocyte count ratio helps predict the grade of glial tumor—a pilot study. Neurol Neurochir Pol 49:41–44PubMed Zadora P, Dabrowski W, Czarko K, Smolen A, Kotlinska-Hasiec E, Wiorkowski K, Sikora A, Jarosz B, Kura K, Rola R, Trojanowski T (2015) Preoperative neutrophil-lymphocyte count ratio helps predict the grade of glial tumor—a pilot study. Neurol Neurochir Pol 49:41–44PubMed
Metadata
Title
Pre-operative neutrophil count and neutrophil-lymphocyte count ratio (NLCR) in predicting the histological grade of paediatric brain tumours: a preliminary study
Authors
J. R. F. Wilson
F. Saeed
A. K. Tyagi
J. R. Goodden
G. Sivakumar
D. Crimmins
M. Elliott
S. Picton
P. D. Chumas
Publication date
01-04-2018
Publisher
Springer Vienna
Published in
Acta Neurochirurgica / Issue 4/2018
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI
https://doi.org/10.1007/s00701-017-3388-5

Other articles of this Issue 4/2018

Acta Neurochirurgica 4/2018 Go to the issue